United Therapeutics Corp (UTHR) Ownership & Trading Activity

Institutional holders, insider transactions, and congressional trades for UTHR. 13F holdings as of 2026-09-30.

In 13F filings for the quarter ended September 30, 2026, 276 institutions reported holding UTHR, with 19.4 million shares worth $10.5 billion in aggregate.

Top Institutional Holders

InstitutionSharesValueChange
BlackRock5,575,162$3.0BINCREASED
Vanguard2,183,114$1.2BDECREASED
State Street1,952,557$1.1BINCREASED
Amundi988,820$536MNEW
Geode Capital Management974,993$527MDECREASED

Recent Insider Trades

InsiderTypeSharesValueDate
Martine A Rothblatt (Chairperson & CEO)EXERCISE9,500$1M2026-11-13
Martine A Rothblatt (Chairperson & CEO)SELL40$24K2026-11-13
Martine A Rothblatt (Chairperson & CEO)SELL440$263K2026-11-13
Martine A Rothblatt (Chairperson & CEO)SELL480$286K2026-11-13
Martine A Rothblatt (Chairperson & CEO)SELL1,040$619K2026-11-13

Full institutional holdings, insider history, and congressional trades for United Therapeutics Corp on SentiSense.